Trademark: 85006262
Word
CVS CAREMARK TRANSPLANT CARE SELECT
Status Date
Monday, December 17, 2012
Filing Date
Monday, April 5, 2010
Published for Opposition
Tuesday, September 20, 2011
Abandoned Date
Monday, December 17, 2012
44 Providing health care information, advice, counseling and consulting services to patients, employers, plan sponsors and the general public in the field of immunosuppressant drug therapy
Dec 17, 2012
Abandonment Notice Mailed - No Use Statement Filed
Dec 17, 2012
Abandonment - No Use Statement Filed
May 17, 2012
Notice Of Approval Of Extension Request E-Mailed
May 15, 2012
Extension 1 Granted
May 15, 2012
Extension 1 Filed
May 15, 2012
Teas Extension Received
May 15, 2012
Teas Change Of Correspondence Received
Nov 15, 2011
Noa E-Mailed - Sou Required From Applicant
Sep 20, 2011
Official Gazette Publication Confirmation E-Mailed
Sep 20, 2011
Published For Opposition
Aug 18, 2011
Law Office Publication Review Completed
Aug 17, 2011
Exparte Appeal Terminated
Aug 17, 2011
Approved For Pub - Principal Register
Aug 17, 2011
Data Modification Completed
Aug 17, 2011
Data Modification Completed
Aug 17, 2011
Teas/Email Correspondence Entered
Aug 17, 2011
Correspondence Received In Law Office
Aug 17, 2011
Assigned To Lie
Aug 10, 2011
Teas Request For Reconsideration Received
Aug 10, 2011
Ex Parte Appeal-Instituted
Aug 10, 2011
Jurisdiction Restored To Examining Attorney
Aug 10, 2011
Exparte Appeal Received At Ttab
Feb 10, 2011
Notification Of Final Refusal Emailed
Feb 10, 2011
Final Refusal E-Mailed
Feb 10, 2011
Final Refusal Written
Jan 14, 2011
Teas/Email Correspondence Entered
Jan 14, 2011
Correspondence Received In Law Office
Jan 14, 2011
Teas Response To Office Action Received
Jul 14, 2010
Notification Of Non-Final Action E-Mailed
Jul 14, 2010
Non-Final Action E-Mailed
Jul 14, 2010
Non-Final Action Written
Jul 7, 2010
Assigned To Examiner
Apr 9, 2010
New Application Office Supplied Data Entered In Tram
Apr 8, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
